Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HI-DEF: Deferoxamine in Intracerebral Hemorrhage
NCT01662895Phase 2Terminated
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Mar 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of deferoxamine in intracerebral hemorrhage (ICH), sponsored by Beth Israel Deaconess Medical Center. Started Mar 2013; status: terminated.
02
Drugs
deferoxamine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT01662895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01662895.